NRGN and amyotrophic lateral sclerosis: We observed changes in ALS tissues consistent with previously identified synaptic biomarkers of ALS and neurodegeneration, such as a significant reduction of neurogranin (Kvartsberg et al., 2019; Vijayakumar et al., 2019; Figure 8B–D, Figure 8—source data 1).